Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?
1,716 Followers
BioMarin Pharmaceutical (BMRN) Ownership Overview
The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail and individual investors. Approximately 98.82% of the company’s stock is owned by Institutional Investors, 0.88% is owned by Insiders and 0.30% is owned by Public Companies and Individual Investors.
0.88% Insiders
38.97% Mutual Funds
59.85% Other Institutional Investors
0.30% Public Companies and Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 11, 2023 | Henry Fuchs President, Worldwide R&d | Sold | $1085040 |
| Aug 10, 2023 | Guyer Charles Greg Evp, Chief Technical Officer | Sold | $500088 |
| Aug 09, 2023 | George Eric Davis Evp, Chief Legal Officer | Sold | $983620 |
| Aug 09, 2023 | Jean Jacques Bienaime Ceo,director | Sold | $882140 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Sold | $240134 | |
| Sep 30, 2023 | Sold | $316758 | |
| Sep 30, 2023 | Bought | $358874 | |
| Sep 30, 2023 | Bought | $14280141 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,406,539.00 | Institution | 9.77% | 1,737,577,281.60 | |
| 17,057,779.00 | Institution | 9.06% | 1,610,254,337.60 | |
| 15,868,430.00 | Institution | 8.42% | 1,497,979,792.00 | |
| 14,153,503.00 | Institution | 7.51% | 1,336,090,683.20 | |
| 10,644,025.00 | Institution | 5.65% | 1,004,795,960.00 | |
| 6,697,338.00 | Institution | 3.56% | 632,228,707.20 | |
| 5,962,701.00 | Institution | 3.17% | 562,878,974.40 | |
| 5,735,397.00 | Institution | 3.04% | 541,421,476.80 | |
| 5,368,030.00 | Institution | 2.85% | 506,742,032.00 | |
| 4,643,343.00 | Institution | 2.47% | 438,331,579.20 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,868,430.00 | Institution | 8.42% | 1,497,979,792.00 | |
| 10,644,025.00 | Institution | 5.65% | 1,004,795,960.00 | |
| 6,697,338.00 | Institution | 3.56% | 632,228,707.20 | |
| 5,368,030.00 | Institution | 2.85% | 506,742,032.00 | |
| 4,643,343.00 | Institution | 2.47% | 438,331,579.20 | |
| 3,644,666.00 | Institution | 1.93% | 344,056,470.40 | |
| 2,338,529.00 | Institution | 1.24% | 220,757,137.60 | |
| 1,923,368.00 | Institution | 1.02% | 181,565,939.20 | |
| 1,757,133.00 | Institution | 0.93% | 165,873,355.20 | |
| 1,732,919.00 | Institution | 0.92% | 163,587,553.60 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,897,384.00 | Institution | 3.13% | 480,341,927.00 | |
| 4,272,284.00 | Institution | 2.27% | 347,977,532.00 | |
| 2,666,415.00 | Institution | 1.42% | 217,179,502.00 | |
| 1,511,512.00 | Institution | 0.80% | 139,693,939.00 | |
| 1,511,512.00 | Institution | 0.80% | 139,693,939.00 | |
| 1,648,580.00 | Institution | 0.88% | 134,276,841.00 | |
| 1,271,700.00 | Institution | 0.68% | 120,048,480.00 | |
| 1,156,942.00 | Institution | 0.61% | 109,215,324.80 | |
| 1,305,005.00 | Institution | 0.69% | 106,292,657.00 | |
| 881,561.00 | Institution | 0.47% | 81,473,867.62 |
FAQ
Who Owns BioMarin Pharmaceutical (BMRN)?
According to the latest TipRanks data, approximately 59.85% of the company's stock is held by institutional investors, 0.88% is held by insiders, and 0.30% is held by retail investors.
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 59.85% of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors.
What percentage of BioMarin Pharmaceutical (BMRN) stock is held by retail investors?
According to the latest TipRanks data, approximately 0.30% of BioMarin Pharmaceutical (BMRN) stock is held by retail investors.
Who owns the most shares of BioMarin Pharmaceutical (BMRN)?
Theofanis Kolokotrones owns the most shares of BioMarin Pharmaceutical (BMRN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.